KD-295 phase II/III study

Trial Profile

KD-295 phase II/III study

Phase of Trial: Phase II/III

Latest Information Update: 14 Jun 2016

At a glance

  • Drugs KD 295 (Primary)
  • Indications Influenza A virus H5N1 subtype
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 14 Jun 2016 New trial record
    • 29 Sep 2015 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top